[第三级淋巴细胞结构在非小细胞肺癌的预后和免疫治疗中的最新进展]

相关实验视频

Updated: Jul 15, 2025

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8⁺ T Cells During LN Metastasis

Published on: January 26, 2024

Ying Liu¹, Lei Xiong², Ruoxue Cai¹

¹The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research,  Nanjing 210009, China.

Zhongguo fei ai za zhi = Chinese journal of lung cancer

|September 26, 2023

概括

三级淋巴体结构 (TLS) 是免疫疗法在非小细胞肺癌 (NSCLC) 成功的关键指标. 它们的存在预示着更好的预后,有助于选择患者进行有效治疗.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
病理学病理学病理学

背景情况:

非小细胞肺癌 (NSCLC) 是癌症死亡的主要原因.
免疫疗法改善了NSCLC患者的治疗结果,但反应率各不相同.
由于瘤微环境的复杂性,需要预测性生物标志物.

研究的目的:

审查三级淋巴体结构 (TLS) 在NSCLC免疫治疗中的预后作用.
为识别适合NSCLC免疫疗法的候选人提供参考资料.
支持个性化治疗策略的开发.

主要方法:

文献综述侧重于三级淋巴体结构 (TLS).
对研究的分析,这些研究将TLS存在与NSCLC中的免疫疗法反应相关联.
综合TLS作为预测生物标志物的发现.

主要成果:

三级淋巴体结构 (TLS) 与NSCLC免疫治疗中的良好预后有关.
存在TLS表明对治疗的免疫反应可能更强.
TLS可以作为一种有价值的生物标志物,用于患者分层.

结论:

三级淋巴体结构 (TLS) 在NSCLC免疫治疗中显示出显著的预后价值.
识别TLS可以帮助个性化NSCLC治疗计划.
对TLS的进一步研究可以优化免疫疗法疗效.

关键词:

免疫治疗是一种免疫疗法.肺部的新生病是肺部的新生病.三级淋巴体结构的第三级淋巴体结构.

更多相关视频

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.